XML 266 R86.htm IDEA: XBRL DOCUMENT v3.21.2
Related party transactions (Tables)
12 Months Ended
Jun. 30, 2021
Related party transactions  
Schedule of material related party transactions

    

2021

    

2020

    

2019

for the year ended 30 June

Rm

Rm

Rm

Sales and services rendered from subsidiaries to related parties

Joint ventures

 

2 635

 

672

 

1 474

Purchases by subsidiaries from related parties

 

  

 

  

 

  

Joint ventures

 

8

 

691

 

718

Associates

 

100

 

78

 

95

 

108

 

769

 

813

Schedule of key management remuneration

    

    

    

Retirement

    

Other

    

Annual

Total

    

Total

    

Total

Salary

funding

benefits

incentives²

2021

20201

20191

R’000

R’000

R’000

R’000

R’000

R’000

R’000

Executive Directors

 

24 221

 

1 078

 

2 984

 

37 210

65 493

 

22 944

 

46 948

1Total remuneration for the financial year excludes gains derived from the long-term incentive schemes which are separately disclosed.
2Short-term incentives approved based on the Group results for the 2021 financial year and payable in the 2022 financial year. Incentives are calculated as a percentage of total guaranteed package/base salary as at 30 June 2021 multiplied by the Group STI performance and the Individual Performance Factor.

Gains on Long-term incentives previously awarded to the Executive Directors’ and former Executive Directors’ vested after the performance period ended 30 June 2021, are as follows:

    

    

    

    

Long

incentive

Total 

Total 

Total 

vested1

2021

2020

2019

R’000

R’000

R’000

R’000

Executive Directors

 

4 824

 

4 824

 

2 657

 

25 025

1

Long-term incentives for the 2021 financial year represent incentives approved on the group results for the performance period ended 30 June 2021, settled in the 2022 financial year.

Remuneration and benefits paid and short-term incentives approved for the Prescribed Officers were as follows:

    

    

Retirement 

    

Other 

Annual

    

Total 

    

Total 

    

Total 

Salary 

funding 

benefits 

incentives2

20211

20201

20191

R’000

R’000

R’000

R’000

R’000

R’000

R’000

Prescribed Officers

 

35 540

5 086

 

10 737

41 454

 

92 817

 

52 142

 

67 488

Number of Prescribed Officers

 

  

 

  

 

  

 

7

 

6

 

8

1Total remuneration for the financial year excludes gains derived from the long-term incentive schemes which are separately disclosed.
2Short-term incentives approved based on the Group results for the 2021 financial year and payable in the 2022 financial year. Incentives are calculated as a percentage of total guaranteed package/base salary as at 30 June 2021 multiplied by the Group STI performance and the Individual Performance Factor.

Gains on Long-term incentives previously awarded to the Prescribed Officers vested after the performance period ended 30 June 2021, are as follows:

    

    

    

    

Long-term 

incentive 

rights 

Total 

Total 

Total 

vested1 

2021

2020

2019

R’000

R’000

R’000

R’000

Prescribed Officers

 

6 735

 

6 735

 

4 201

 

68 559

1 Long-term incentives for the 2021 financial year represent incentives approved on the group results for the performance period ended 30 June 2021, settled in the 2022 financial year.

Gains on Long-term incentives previously awarded to the former Joint CEOs and Presidents and vested after the performance period ended 30 June 2021, are as follows:

38

Related party transactions continued

    

    

    

Long-term 

incentive 

rights 

Total

Total 

vested1

2021

2020

R’000

R’000

R’000

Former Joint CEOs and Presidents

 

6 182

 

6 182

 

3 765

1Long-term incentives for the 2021 financial year represent incentives approved on the group results for the performance period ended 30 June 2021, settled in the 2022 financial year.

The total IFRS2 charge for LTI’s awarded to the Executive Directors and the Prescribed Officers in 2021 amounted to R26 million and R36 million.

Non-executive Directors’ emoluments for the year was as follows:

    

    

    

    

Ad Hoc 

    

    

    

Special 

Board 

Lead 

Board — 

meeting 

Director 

Committee 

Committee

Total 

Total 

Total 

fees 

fees 

fees 

 Meeting 

2021

2020

2019

R’000

R’000

R’000

R’000

R’000

R’000

R’000

Non-executive Directors

24 996

 

707

 

6 878

959

 

33 540

 

39 743

 

32 455